-
1
-
-
9144231813
-
Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: An analysis of 32 cases and a comprehensive review of the literature
-
Folpe AL, Fanburg-Smith JC, Billings SD, et al. Most osteomalacia- associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature. Am J Surg Pathol 2004;28:1-30.
-
(2004)
Am J Surg Pathol
, vol.28
, pp. 1-30
-
-
Folpe, A.L.1
Fanburg-Smith, J.C.2
Billings, S.D.3
-
3
-
-
0031780399
-
Oncogenic osteomalacia: Case report and review of head and neck associated tumours
-
Gonzalez-Compta X, Mañós-Pujol M, Foglia-Fernandez M, et al. Oncogenic osteomalacia: case report and review of head and neck associated tumours. J Laryngol Otol 1998;112:389-92.
-
(1998)
J Laryngol Otol
, vol.112
, pp. 389-392
-
-
Gonzalez-Compta, X.1
Mañós-Pujol, M.2
Foglia-Fernandez, M.3
-
4
-
-
0023118664
-
Phosphaturic mesenchymal tumors: A polymorphous group causing osteomalacia or rickets
-
Weidner N, Cruz DS. Phosphaturic mesenchymal tumors: a polymorphous group causing osteomalacia or rickets. Cancer 1987;59:1442-54.
-
(1987)
Cancer
, vol.59
, pp. 1442-1454
-
-
Weidner, N.1
Cruz, D.S.2
-
5
-
-
0028363099
-
Tumor-induced osteomalacia: Unveiling a new hormone
-
Econs MJ, Drezner MK. Tumor-induced osteomalacia: unveiling a new hormone. N Engl J Med 1994;330:1679-81.
-
(1994)
N Engl J Med
, vol.330
, pp. 1679-1681
-
-
Econs, M.J.1
Drezner, M.K.2
-
6
-
-
14344279878
-
Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia
-
Shimada T, Mizutani S, Muto T, et al. Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia. Proc Natl Acad Sci U S A 2001;98:6500-6505.
-
(2001)
Proc Natl Acad Sci U S A
, vol.98
, pp. 6500-6505
-
-
Shimada, T.1
Mizutani, S.2
Muto, T.3
-
7
-
-
0033763097
-
Autosomal dominant hypophosphatemic rickets is associated with mutations in FGF23
-
White KE, Evans WE, O'Riordan JL, et al. Autosomal dominant hypophosphatemic rickets is associated with mutations in FGF23. Nat Genet 2000;26:345-8.
-
(2000)
Nat Genet
, vol.26
, pp. 345-348
-
-
White, K.E.1
Evans, W.E.2
O'Riordan, J.L.3
-
8
-
-
18744371012
-
Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia
-
Yamazaki Y, Okazaki R, Shibata M, et al. Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia. J Clin Endocrinol Metab 2002;87:4957-60.
-
(2002)
J Clin Endocrinol Metab
, vol.87
, pp. 4957-4960
-
-
Yamazaki, Y.1
Okazaki, R.2
Shibata, M.3
-
9
-
-
20844452698
-
Role of fibroblast growth factor 23 in health and chronic kidney disease
-
Fukagawa M, Nii-Kono T, Kazama JJ. Role of fibroblast growth factor 23 in health and chronic kidney disease. Curr Opin Nephrol Hypertens 2005;14:325-9.
-
(2005)
Curr Opin Nephrol Hypertens
, vol.14
, pp. 325-329
-
-
Fukagawa, M.1
Nii-Kono, T.2
Kazama, J.J.3
-
10
-
-
0141844575
-
Regulation of fibroblastic growth factor 23 expression but not degradation by PHEX
-
Liu S, Guo R, Simpson LG, et al. Regulation of fibroblastic growth factor 23 expression but not degradation by PHEX. J Biol Chem 2003;278:37419-26.
-
(2003)
J Biol Chem
, vol.278
, pp. 37419-37426
-
-
Liu, S.1
Guo, R.2
Simpson, L.G.3
-
11
-
-
0037295477
-
Immunohistochemical detection of FGF-23 protein in tumors that cause oncogenic osteomalacia
-
Larsson T, Zahradnik R, Lavigne J, et al. Immunohistochemical detection of FGF-23 protein in tumors that cause oncogenic osteomalacia. Eur J Endocrinol 2003;148:269-76.
-
(2003)
Eur J Endocrinol
, vol.148
, pp. 269-276
-
-
Larsson, T.1
Zahradnik, R.2
Lavigne, J.3
-
12
-
-
0141453087
-
Fibroblast growth factor 23: A new clinical marker for oncogenic osteomalacia
-
Nelson AE, Bligh RC, Mirams M, et al. Fibroblast growth factor 23: a new clinical marker for oncogenic osteomalacia. J Clin Endocrinol Metab 2003;88:4088-94.
-
(2003)
J Clin Endocrinol Metab
, vol.88
, pp. 4088-4094
-
-
Nelson, A.E.1
Bligh, R.C.2
Mirams, M.3
-
13
-
-
0038311933
-
Regulation of Na/Pi transporter in the proximal tubule
-
Murer H, Hernando N, Foster I, et al. Regulation of Na/Pi transporter in the proximal tubule. Annu Rev Physiol 2003;65:531-42.
-
(2003)
Annu Rev Physiol
, vol.65
, pp. 531-542
-
-
Murer, H.1
Hernando, N.2
Foster, I.3
-
14
-
-
2142746439
-
FGF23 is a potent regulator of vitamin D metabolism and phosphate homeostasis
-
Shimada T, Hasegawa H, Yamazaki Y, et al. FGF23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res 2004;19:429-35.
-
(2004)
J Bone Miner Res
, vol.19
, pp. 429-435
-
-
Shimada, T.1
Hasegawa, H.2
Yamazaki, Y.3
-
16
-
-
4043052503
-
Venous sampling for fibroblast growth factor-23 confirms preoperative diagnosis of tumor-induced osteomalacia
-
Takeuchi Y, Suzuki H, Ogura S, et al. Venous sampling for fibroblast growth factor-23 confirms preoperative diagnosis of tumor-induced osteomalacia. J Clin Endocrinol Metab 2004;89:3979-82.
-
(2004)
J Clin Endocrinol Metab
, vol.89
, pp. 3979-3982
-
-
Takeuchi, Y.1
Suzuki, H.2
Ogura, S.3
-
17
-
-
84957412176
-
Osteomalacia with Loosers nodes (Milkmans syndrome) due to the raised resistance to vitamin D acquired about the age of 15 years
-
McCance RA. Osteomalacia with Loosers nodes (Milkmans syndrome) due to the raised resistance to vitamin D acquired about the age of 15 years. Q J Med 1947;16:33-47.
-
(1947)
Q J Med
, vol.16
, pp. 33-47
-
-
McCance, R.A.1
-
19
-
-
0031035615
-
Autosomal dominant hypophosphatemic rickets/osteomalacia: Clinical characterization of a novel renal phosphate-wasting disorder
-
Econs ML, McEnery PT. Autosomal dominant hypophosphatemic rickets/osteomalacia: clinical characterization of a novel renal phosphate-wasting disorder. J Clin Endocrinol Metab 1997;82:674-81.
-
(1997)
J Clin Endocrinol Metab
, vol.82
, pp. 674-681
-
-
Econs, M.L.1
McEnery, P.T.2
-
20
-
-
14944360740
-
Octreotide therapy for tumor-induced osteomalacia
-
Seufert J, Ebert K, Müller J, et al. Octreotide therapy for tumor-induced osteomalacia. N Engl J Med 2001;345:1883-8.
-
(2001)
N Engl J Med
, vol.345
, pp. 1883-1888
-
-
Seufert, J.1
Ebert, K.2
Müller, J.3
-
21
-
-
0035725603
-
Oncogenic osteomalacia associated with mesenchymal tumor detected by indium-111 octreotide scintigraphy
-
Oxf
-
Rhee Y, Lee JD, Shin KH, et al. Oncogenic osteomalacia associated with mesenchymal tumor detected by indium-111 octreotide scintigraphy. Clin Endocrinol (Oxf) 2001;54:551-4.
-
(2001)
Clin Endocrinol
, vol.54
, pp. 551-554
-
-
Rhee, Y.1
Lee, J.D.2
Shin, K.H.3
-
22
-
-
0032916730
-
Indium-111 pentreotide scintigraphy of mesenchymal tumor with oncogenic osteomalacia
-
Nguyen BD, Wang EA. Indium-111 pentreotide scintigraphy of mesenchymal tumor with oncogenic osteomalacia. Clin Nucl Med 1999;24:130-31.
-
(1999)
Clin Nucl Med
, vol.24
, pp. 130-131
-
-
Nguyen, B.D.1
Wang, E.A.2
-
23
-
-
0037006672
-
Localization of mesenchymal tumours by somatostatin receptor imaging
-
Jan de Beur SM, Streeten EA, Civelek AC, et al. Localization of mesenchymal tumours by somatostatin receptor imaging. Lancet 2002;359:761-3.
-
(2002)
Lancet
, vol.359
, pp. 761-763
-
-
Jan De Beur, S.M.1
Streeten, E.A.2
Civelek, A.C.3
-
24
-
-
15544385175
-
Oncogenic osteomalacia: Diagnostic importance of fibroblast growth factor 23 and F-18 fluorodeoxyglucose PET/CT SCAN for the diagnosis and follow-up in one case
-
Dupond JL, Mahammedi H, Prié D, et al. Oncogenic osteomalacia: diagnostic importance of fibroblast growth factor 23 and F-18 fluorodeoxyglucose PET/CT SCAN for the diagnosis and follow-up in one case. Bone 2005;36:375-8.
-
(2005)
Bone
, vol.36
, pp. 375-378
-
-
Dupond, J.L.1
Mahammedi, H.2
Prié, D.3
-
25
-
-
0022532860
-
Studies in a patient with tumor-induced hypophosphatemic osteomalacia
-
Ryan WG, Gitelis S, Charters JR. Studies in a patient with tumor-induced hypophosphatemic osteomalacia. Calcif Tissue Int 1986;38:358-62.
-
(1986)
Calcif Tissue Int
, vol.38
, pp. 358-362
-
-
Ryan, W.G.1
Gitelis, S.2
Charters, J.R.3
-
26
-
-
0030632208
-
Oncogenic osteomalacia caused by a phosphaturic mesenchymal tumor of the oral cavity: A case report
-
Yang IM, Park YK, Hyun YJ, et al. Oncogenic osteomalacia caused by a phosphaturic mesenchymal tumor of the oral cavity: a case report. Korean J Intern Med 1997;12:89-95.
-
(1997)
Korean J Intern Med
, vol.12
, pp. 89-95
-
-
Yang, I.M.1
Park, Y.K.2
Hyun, Y.J.3
-
27
-
-
3242661165
-
Possible involvement of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism associated with renal insufficiency
-
Shigematsu T, Kazama JJ, Yamashita T, et al. Possible involvement of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism associated with renal insufficiency. Am J Kidney Dis 2004;44:250-6.
-
(2004)
Am J Kidney Dis
, vol.44
, pp. 250-256
-
-
Shigematsu, T.1
Kazama, J.J.2
Yamashita, T.3
|